Good morning :)
Place Order
Add to Watchlist

Rubicon Research Ltd

RUBICON Share Price

627.201.77% (-11.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹10,333 cr, stock is ranked 550

High Risk

Stock is 3.53x as volatile as Nifty

RUBICON Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹10,333 cr, stock is ranked 550

High Risk

Stock is 3.53x as volatile as Nifty

RUBICON Performance & Key Metrics

RUBICON Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
—26.84—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.705.790.59%

RUBICON Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

RUBICON Company Profile

Rubicon Research Ltd is a pharmaceutical formulations company focused on R&D of specialty and drug-device combination products for regulated markets, especially the US, offering multiple dosage forms and therapeutic areas including analgesics, CVS, CNS, gastrointestinal, and respiratory products.

RUBICON Similar Stocks (Peers)

Compare with peers Compare with peers 

RUBICON Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.13
37.13
1Y Return
5.56%
5.56%
Buy Reco %
91.43
91.43
Cipla Ltd
CIPLA
PE Ratio
23.07
23.07
1Y Return
4.47%
4.47%
Buy Reco %
67.74
67.74
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
63.39
63.39
1Y Return
13.19%
13.19%
Buy Reco %
72.00
72.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.75
17.75
1Y Return
6.37%
6.37%
Buy Reco %
41.94
41.94
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
20.99
20.99
1Y Return
3.00%
3.00%
Buy Reco %
48.00
48.00
Compare with Peers

RUBICON Forecast

RUBICON Forecasts

Price

Revenue

Earnings

RUBICON Share Price Forecast

RUBICON Share Price Forecast

2025
Current
₹627.20
Baseline
Forecast for Nov 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2025
Current
₹627.20
Baseline
Forecast for Nov 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

RUBICON Company Revenue Forecast

RUBICON Company Revenue Forecast

2025
Current
₹1.30
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

Loading...
2025
Current
₹1.30
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

RUBICON Stock EPS (Earnings Per Share) Forecast

RUBICON Stock EPS (Earnings Per Share) Forecast

2025
Current
₹8.82
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2025
Current
₹8.82
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

RUBICON

RUBICON

Income

Balance Sheet

Cash Flow

RUBICON Income Statement

RUBICON Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 35.76%, vs industry avg of 10.03%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.11% to 0.31%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 22.14%, vs industry avg of 20.02%

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue281.09324.85330.42419.00872.391,296.22—
Raw Materialssubtract41.9254.5282.13149.40313.671,028.33—
Power & Fuel Costsubtract8.196.8210.5115.7118.62
Employee Costsubtract42.9155.8278.9097.12125.34
Selling & Administrative Expensessubtract66.3583.85130.12104.28219.11
Operating & Other expensessubtract23.0522.0551.138.5322.55
Depreciation/Amortizationsubtract18.4529.3134.0136.0638.9736.59—
Interest & Other Itemssubtract6.209.379.7218.9631.2636.78—
Taxes & Other Itemssubtract24.6032.431.015.8411.8560.16—
EPS3.252.02-4.41-1.115.988.82—
DPS0.070.030.020.020.020.00—
Payout ratio0.020.02——0.000.00—
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

RUBICON Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

RUBICON Stock Peers

RUBICON Past Performance & Peer Comparison

RUBICON Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Rubicon Research Ltd76.9126.84—
Sun Pharmaceutical Industries Ltd37.135.600.95%
Cipla Ltd23.073.891.06%
Torrent Pharmaceuticals Ltd63.3915.960.89%

RUBICON Stock Price Comparison

Compare RUBICON with any stock or ETF
Compare RUBICON with any stock or ETF
RUBICON
Loading...

RUBICON Holdings

RUBICON Shareholdings

RUBICON Promoter Holdings Trend

RUBICON Promoter Holdings Trend

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

RUBICON Institutional Holdings Trend

RUBICON Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

RUBICON Shareholding Pattern

RUBICON Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding59.99%5.63%4.91%9.37%20.10%

Sep 2025

Oct 2025

RUBICON Shareholding History

RUBICON Shareholding History

SepOct9.37%9.37%

Mutual Funds Invested in RUBICON

Mutual Funds Invested in RUBICON

No mutual funds holding trends are available

Top 1 Mutual Funds holding Rubicon Research Ltd

Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Canara Robeco Manufacturing Fund - Growth - Direct Plan

Growth
0.2230%1.37%1.37%51/66 (+14)

Compare 3-month MF holding change on Screener

RUBICON Insider Trades & Bulk Stock Deals

RUBICON Insider Trades & Bulk Stock Deals

Loading...

smallcases containing RUBICON stock

smallcases containing RUBICON stock

Looks like this stock is not in any smallcase yet.

RUBICON Events

RUBICON Events

RUBICON Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

RUBICON Dividend Trend

No dividend trend available

RUBICON Dividends

RUBICON Dividends

Hmm, looks like data is unavailable here. Please come back after some time

RUBICON Stock News & Opinions

RUBICON Stock News & Opinions

Corporate
Rubicon Research to convene board meeting

Rubicon Research will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

16 hours agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Rubicon Research Ltd (RUBICON) today?

    The share price of RUBICON as on 7th November 2025 is ₹627.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Rubicon Research Ltd (RUBICON) share?

    The past returns of Rubicon Research Ltd (RUBICON) share are
    • Past 1 week: 3.94%
    • Past 1 month: 6.09%
    • Past 3 months: N/A%
    • Past 6 months: -0.16%
    • Past 1 year: -0.16%
    • Past 3 years: N/A%
    • Past 5 years: -0.16%

  3. What are the peers or stocks similar to Rubicon Research Ltd (RUBICON)?

    The peers or stocks similar to Rubicon Research Ltd (RUBICON) include:

  4. What is the market cap of Rubicon Research Ltd (RUBICON) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Rubicon Research Ltd (RUBICON) is ₹10333.14 Cr as of 7th November 2025.

  5. What is the 52 week high and low of Rubicon Research Ltd (RUBICON) share?

    The 52-week high of Rubicon Research Ltd (RUBICON) is ₹671.95 and the 52-week low is ₹570.75.

  6. What is the PE and PB ratio of Rubicon Research Ltd (RUBICON) stock?

    The P/E (price-to-earnings) ratio of Rubicon Research Ltd (RUBICON) is 76.91. The P/B (price-to-book) ratio is 26.84.

  7. Which sector does Rubicon Research Ltd (RUBICON) belong to?

    Rubicon Research Ltd (RUBICON) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Rubicon Research Ltd (RUBICON) shares?

    You can directly buy Rubicon Research Ltd (RUBICON) shares on Tickertape. Simply sign up, connect your demat account and place your order.